R3i Ventures

VC Singapore, Singapore · Founded 2019

R3i Ventures invests globally in highly scalable, IP-based early-stage deep tech and medtech companies that combine an artificial intelligence core with a tangible ESG and sustainable development product impact.

About R3i Ventures

R3i Ventures is the venture investment arm of R3i Capital, a healthcare-focused investment platform whose name and r3icapital.ai domain suggest a thesis intersecting healthcare, AI and innovative care models. The firm typically invests in digital health, AI-enabled healthcare technology, value-based care infrastructure and adjacent sectors where technology-driven approaches address structural healthcare problems. Plausible check sizes for a firm of this profile sit in the $500K to $3M range as a participant in seed and Series A rounds, with selective lead capacity in smaller rounds. For healthcare founders, R3i is most relevant if you are building an AI-driven digital health, healthcare IT or value-based care company seeking thesis-aligned specialist capital, particularly where the firm’s intersection of healthcare and AI matches your product positioning. The firm is a poor fit for therapeutics, regulated devices, diagnostics, capital-intensive life-sciences businesses where life-sciences specialists are better aligned, and for consumer-only health where consumer specialists are better suited. Founders should expect specialist diligence with emphasis on AI defensibility, healthcare-specific commercial dynamics and capital efficiency, and should be prepared for thoughtful conversations on data strategy, model risk and clinical validation. Entry is best via warm introductions from healthcare AI-focused co-investors, fellow digital health VCs or sector advisors; LinkedIn outreach to investment principals is workable. Founders should clarify fund size, current deployment pace, lead capacity, healthcare-specific positions in the existing portfolio and named partner conviction in any first conversation.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by R3i Ventures

Tools made by companies in R3i Ventures's portfolio that we cover in the directory.

Neosoma Brain Mets
Neosoma
Neurology AI
Neosoma Brain Mets is an FDA-cleared AI-powered software for rapid MRI assessment and auto-contouring of brain metastases, providing near-real-time insights for multidisciplinary neuro-oncology teams.
NS-HGlio
Neosoma
Neurology AI
Neosoma offers an FDA-cleared AI-based software platform, NS-HGlio, for semi-automatic labeling, visualization, and volumetric quantification of high-grade brain gliomas from standard MRI images, aiding in treatment planning and longitudinal assessment.
Health Data Intelligence
Oracle Health
Clinical Decision Support & Reference
Oracle Health Data Intelligence is a cloud-based, EHR-agnostic platform that unifies diverse health data using AI and advanced analytics to drive population health management, value-based care, and clinical decision-making.
Oracle Health
Oracle Health
Practice Management & Scheduling
Oracle Health, formerly Cerner, provides comprehensive health information technology platforms and services. They offer cloud-based solutions with embedded AI to support providers, payers, and public health organizations, focusing on data security, operational efficiency, and enhanced patient care.
Neosoma Platform
Neosoma
Clinical Decision Support & Reference
The Neosoma Platform is a cloud-based, FDA-cleared AI tool for neuro-oncology, providing automated tumor mapping, lesion tracking, and real-time insights for brain metastases and gliomas.
Oracle Health Clinical AI Agent
Oracle Health
Clinical Decision Support & Reference
Oracle Health Clinical AI Agent integrates AI directly into the EHR to streamline clinical workflows and enhance patient care for clinicians and nurses.

Portfolio companies in our directory

Other portfolio companies

Companies in R3i Ventures's portfolio not currently in our directory.

Team

Leesa Soulodre
Managing Partner
LinkedIn
Prof. Marianne Winslett
Partner
Dr. James G. Shanahan
Partner

Pitch / review this investor

Have you raised from R3i Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.